Latest

Latest Cambridge News | Page 2

  • Latest Cambridge news stories and updates. What is happening today? All recent Cambridge news and developments. Live coverage and timeline of Cambridge. All you need to know about Cambridge.
$10 million infrastructure upgrades to support our emergency volunteers
Chance find fulfils 110-year mission to give ancient Nubians a voice
Influencers’ vulnerabilities are double-edged sword
Beyfortus approved in China for the prevention of RSV disease in infants
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
Development Applications on Exhibition 22 December
Donation bonanza lifts spirits this Christmas
Cambridge Police impound four motorcycles from Greazy Dogs motorcycle gang
Judicial appointments announced
First steps of 100-day plan for education: removing distractions and teaching the basics brilliantly
Tata Steel, The Henry Royce Institute Sign MoU to set up a Centre for Innovation in Advanced Materials
NHMRC funding to tackle increasing antimicrobial resistance
Nine new North-West firefighters graduate today
Police update: Wounding charges in Alexandra Hills, QLD
Thrill ride until end
Wounding incident at Alexandra Hills, QLD
AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data
Tender out for Lauderdale Primary School redevelopment
Lighting it up for walkers and cyclists
HKUST and Tsinghua University Jointly Organize International AI Forum
Fast Five with Moran Zhou 7 December
Taking insects on Virtual Journey
Neurodegeneration in myelin disease: no myelin is better than bad myelin
Dave Sharma selected to represent NSW in Senate
Honorary Doctorate awarded to Secretary General of OECD
Funding for Würzburg Biophysicist
Water quality boosted through Greening Our Communities projects
AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes
Truqap (capivasertib) plus Faslodex approved in the US for patients with advanced HR-positive breast cancer
New director for WEHI
Tender out for Cambridge Primary School redevelopment
Imfinzi plus chemotherapy approved in China as first immunotherapy regimen for patients with locally advanced or metastatic biliary tract cancer
Update on PACIFIC-2 Phase III trial of Imfinzi concurrently administered with platinum-based chemoradiotherapy in unresectable, Stage III non-small cell lung cancer
Fire is consuming more than ever of the world’s forests, threatening supplies of wood and paper
Sydney man accused of soliciting child abuse material
Collingwood’s biggest park officially opened
Police appeal to locate man missing from Fairfield West
The University of Manchester is proud to support National Productivity Week
Imfinzi plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolisation in EMERALD-1 Phase III trial
Luminous ‘mother-of-pearl’ clouds explain why climate models miss so much Arctic and Antarctic warming
A 4-day week might not work in health care. But adapting this model could reduce burnout among staff
Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial
ZORA real-world evidence demonstrates that Lokelma substantially increases cardiorenal patients’ chances of maintaining lifesaving RAASi therapy
AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
New WA Government subsidy to attract English language teachers
Drink driver caught more than 4 times legal limit
Stolen car charges in Alexandra Hills, QLD
Rabbits as ‘starter pets’ for kids

© 2024 - The National Tribune Australia